Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Anixa Biosciences Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 58 | +6 |
| Shares | 5.57M | 160.4K | 5.61M | +209.6K (+3.9%) |
| Value | $12.3M | $354.5K | $17.6M | +$5.61M (+47.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Anixa Biosciences Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 162,341 | $511.4K | 0.00% |
| Marshall Wace, LLP | 44,483 | $140.1K | 0.00% |
| Group One Trading, L.P. | 19,044 | $60.0K | 0.00% |
| Stratos Wealth Partners, LTD. | 15,000 | $47.3K | 0.00% |
| Virtu Financial LLC | 10,786 | $34.0K | 0.00% |
| Renaissance Technologies LLC | 10,673 | $33.6K | 0.00% |
| Citadel Advisors LLC | 5,685 | $17.9K | 0.00% |
| Steward Partners Investment Advisory, LLC | 3,144 | $9.90K | 0.00% |
| Livelsberger Financial Advisory | 1,634 | $5.15K | 0.11% |
| Avion Wealth | 200 | $0 | 0.00% |
Sold out (4)
Institutions that held Anixa Biosciences Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Occudo Quantitative Strategies LP | 18,432 | $40.7K |
| Dimensional Fund Advisors LP | 17,544 | $38.8K |
| Qube Research & Technologies Ltd | 3 | $6 |
| Lazard Asset Management LLC | 50 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Anixa Biosciences Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 160,416 | $354.5K |